MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction

Can J Cardiol. 2015 May;31(5):679-90. doi: 10.1016/j.cjca.2014.12.026. Epub 2014 Dec 29.

Abstract

Background: MicroRNAs (miRs) play a role in cardiac remodelling, and acute myocardial infarction (AMI) can regulate miR expression. MiR-208a is essential for the expression of the genes involved in cardiac hypertrophy and fibrosis. MiR-208a activates endoglin expression and may result in cardiac fibrosis. The role of miR-208a and endoglin in AMI is not known. We sought to investigate the regulation of miR-208a and endoglin in AMI.

Methods: Ligation of the proximal left anterior descending artery was performed in adult Sprague-Dawley rats to induce AMI. Echocardiography was used to measure heart size and left ventricular function. The TaqMan miR real-time quantitative assay was used to quantitate miR-208a. Myocardial fibrosis was detected by Masson trichrome staining.

Results: AMI and overexpression of miR-208a in the sham group without infarction significantly increased myocardial miR-208a, endoglin, and β-myosin heavy chain (β-MHC) expression. Overexpression of antagomir-208a significantly inhibited the increase of myocardial endoglin and β-MHC protein expression induced by infarction. Overexpression of mutant miR-208a in the sham group did not induce myocardial endoglin and β-MHC expression. Pretreatment with atorvastatin and the angiotensin-receptor antagonist valsartan significantly attenuated the increase of endoglin and β-MHC induced by infarction. AMI and overexpression of miR-208a in the sham group significantly increased the area of myocardial fibrosis compared with the sham group. Overexpression of antagomir-208a and pretreatment with atorvastatin and valsartan in the AMI group significantly decreased the area of myocardial fibrosis induced by infarction.

Conclusions: MiR-208a increases endoglin expression to induce myocardial fibrosis in rats with AMI. Treatment with atorvastatin and valsartan can decrease myocardial fibrosis induced by AMI through attenuating miR-208a and endoglin expression.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atorvastatin
  • Blotting, Western
  • Cells, Cultured
  • Disease Models, Animal
  • Endoglin
  • Fibrosis / drug therapy
  • Fibrosis / genetics
  • Fibrosis / pathology
  • Gene Expression Regulation*
  • Hemodynamics / physiology
  • Heptanoic Acids / pharmacology
  • Immunohistochemistry
  • Intracellular Signaling Peptides and Proteins / genetics*
  • Male
  • MicroRNAs / genetics*
  • Muscle Cells / drug effects
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / genetics
  • Myocardial Infarction / pathology*
  • Polymerase Chain Reaction / methods
  • Pyrroles / pharmacology
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Sensitivity and Specificity
  • Tetrazoles / pharmacology
  • Valine / analogs & derivatives
  • Valine / pharmacology
  • Valsartan
  • Ventricular Remodeling / drug effects
  • Ventricular Remodeling / physiology

Substances

  • Endoglin
  • Eng protein, rat
  • Heptanoic Acids
  • Intracellular Signaling Peptides and Proteins
  • MIRN208 microRNA, rat
  • MicroRNAs
  • Pyrroles
  • Tetrazoles
  • Valsartan
  • Atorvastatin
  • Valine